Collectively, the results of the analysis of differential gene expression gonadotropin and sex hormone genes, and estrogen- and androgen-regulated transcriptomes suggest that the FSH—estrogen axis may be active in testicular cancers assigned to hormonal clusters #1 and #3. The gene discussed is BRD2; the disease is testicular cancer.